Neogepatect

Neohepatect is an immunoglobulin drug intended for the treatment and prevention of viral hepatitis B, which is produced in Germany. It contains antibodies that help protect the body from hepatitis B virus infection and prevent its spread.

Neohepatect is available as a solution for intravenous use and is intended for use in emergency cases when it is necessary to quickly prevent infection with the hepatitis B virus. The drug can also be used to prevent liver infection and combat hepatitis B in newborns and people who are at high risk of infection.

However, as with any drug, Neohepatect has contraindications. For example, it should not be used in case of hypersensitivity to the components of the drug, as well as in the presence of hepatitis B virus surface antigen in the patient. In addition, the use of Neohepatect during pregnancy and breastfeeding should be done with caution.

In general, Neohepatect is an effective and safe drug for combating viral hepatitis B, but its use must be justified by medical indications and must be carried out under the supervision of a physician.